Journal
Clinical Infectious Diseases
Publication Date
2017
Volume
65
Issue
7
First Page
1218
Last Page
1221
Document Type
Open Access Publication
DOI
doi: 10.1093/cid/cix523
Rights and Permissions
Vimalanand S Prabhu, Oliver A Cornely, Yoav Golan, Erik R Dubberke, Sebastian M Heimann, Mary E Hanson, Jane Liao, Alison Pedley, Mary Beth Dorr, Stephen Marcella, Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection, Clinical Infectious Diseases, Volume 65, Issue 7, 1 October 2017, Pages 1218–1221, https://doi.org/10.1093/cid/cix523. © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. https://academic.oup.com/cid/article/65/7/1218/4080783.
Recommended Citation
Prabhu, Vimalanand S.; Cornely, Oliver A.; Golan, Yoav; Dubberke, Erik R.; Heimann, Sebastian M.; Hansen, Mary E.; Liao, Jane; Pedley, Alison; Dorr, Mary Beth; and Marcella, Stephen, "Thirty-day readmissions in hospitalized patients who received bezlotoxumab with antibacterial drug treatment for Clostridium difficile infection." Clinical Infectious Diseases. 65, 7. 1218 - 1221. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/8464
